Global Biopharmaceutical CDMO Supply, Demand and Key Producers, 2023-2029
The global Biopharmaceutical CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Biopharmaceutical CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biopharmaceutical CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biopharmaceutical CDMO total market, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biopharmaceutical CDMO total market, key domestic companies and share, (USD Million)
Global Biopharmaceutical CDMO revenue by player and market share 2018-2023, (USD Million)
Global Biopharmaceutical CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Biopharmaceutical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm and Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biopharmaceutical CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biopharmaceutical CDMO Market, By Region:
1. How big is the global Biopharmaceutical CDMO market?
2. What is the demand of the global Biopharmaceutical CDMO market?
3. What is the year over year growth of the global Biopharmaceutical CDMO market?
4. What is the total value of the global Biopharmaceutical CDMO market?
5. Who are the major players in the global Biopharmaceutical CDMO market?
This report studies the global Biopharmaceutical CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biopharmaceutical CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biopharmaceutical CDMO total market, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biopharmaceutical CDMO total market, key domestic companies and share, (USD Million)
Global Biopharmaceutical CDMO revenue by player and market share 2018-2023, (USD Million)
Global Biopharmaceutical CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Biopharmaceutical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm and Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biopharmaceutical CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biopharmaceutical CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Development and Manufacturing CDMOs
- Clinical Trial Material CDMOs
- Fill-Finish CDMOs
- Other
- Pharmaceutical Company
- Biotechnology Company
- Other
- Lonza
- WuXi AppTec
- Catalent
- Thermo Fisher
- Recipharm
- Samsung Biologics
- Siegfried
- Delpharm
- Boehringer Ingelheim
- Aenova Group
- AGC Parma Chemicals
- GenScript
- ProBioGen
- KBI Biopharma
- 3P Biopharmaceuticals
- Rentschler Biopharma
- Northway Biotech
1. How big is the global Biopharmaceutical CDMO market?
2. What is the demand of the global Biopharmaceutical CDMO market?
3. What is the year over year growth of the global Biopharmaceutical CDMO market?
4. What is the total value of the global Biopharmaceutical CDMO market?
5. Who are the major players in the global Biopharmaceutical CDMO market?
1 SUPPLY SUMMARY
1.1 Biopharmaceutical CDMO Introduction
1.2 World Biopharmaceutical CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biopharmaceutical CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Biopharmaceutical CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biopharmaceutical CDMO Market Size (2018-2029)
1.3.3 China Biopharmaceutical CDMO Market Size (2018-2029)
1.3.4 Europe Biopharmaceutical CDMO Market Size (2018-2029)
1.3.5 Japan Biopharmaceutical CDMO Market Size (2018-2029)
1.3.6 South Korea Biopharmaceutical CDMO Market Size (2018-2029)
1.3.7 ASEAN Biopharmaceutical CDMO Market Size (2018-2029)
1.3.8 India Biopharmaceutical CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biopharmaceutical CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biopharmaceutical CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Biopharmaceutical CDMO Consumption Value (2018-2029)
2.2 World Biopharmaceutical CDMO Consumption Value by Region
2.2.1 World Biopharmaceutical CDMO Consumption Value by Region (2018-2023)
2.2.2 World Biopharmaceutical CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Biopharmaceutical CDMO Consumption Value (2018-2029)
2.4 China Biopharmaceutical CDMO Consumption Value (2018-2029)
2.5 Europe Biopharmaceutical CDMO Consumption Value (2018-2029)
2.6 Japan Biopharmaceutical CDMO Consumption Value (2018-2029)
2.7 South Korea Biopharmaceutical CDMO Consumption Value (2018-2029)
2.8 ASEAN Biopharmaceutical CDMO Consumption Value (2018-2029)
2.9 India Biopharmaceutical CDMO Consumption Value (2018-2029)
3 WORLD BIOPHARMACEUTICAL CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Biopharmaceutical CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biopharmaceutical CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biopharmaceutical CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Biopharmaceutical CDMO in 2022
3.3 Biopharmaceutical CDMO Company Evaluation Quadrant
3.4 Biopharmaceutical CDMO Market: Overall Company Footprint Analysis
3.4.1 Biopharmaceutical CDMO Market: Region Footprint
3.4.2 Biopharmaceutical CDMO Market: Company Product Type Footprint
3.4.3 Biopharmaceutical CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biopharmaceutical CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biopharmaceutical CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biopharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biopharmaceutical CDMO Consumption Value Comparison
4.2.1 United States VS China: Biopharmaceutical CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biopharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biopharmaceutical CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biopharmaceutical CDMO Revenue, (2018-2023)
4.4 China Based Companies Biopharmaceutical CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Biopharmaceutical CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biopharmaceutical CDMO Revenue, (2018-2023)
4.5 Rest of World Based Biopharmaceutical CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biopharmaceutical CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biopharmaceutical CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Development and Manufacturing CDMOs
5.2.2 Clinical Trial Material CDMOs
5.2.3 Fill-Finish CDMOs
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biopharmaceutical CDMO Market Size by Type (2018-2023)
5.3.2 World Biopharmaceutical CDMO Market Size by Type (2024-2029)
5.3.3 World Biopharmaceutical CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biopharmaceutical CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biopharmaceutical CDMO Market Size by Application (2018-2023)
6.3.2 World Biopharmaceutical CDMO Market Size by Application (2024-2029)
6.3.3 World Biopharmaceutical CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biopharmaceutical CDMO Product and Services
7.1.4 Lonza Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 WuXi AppTec
7.2.1 WuXi AppTec Details
7.2.2 WuXi AppTec Major Business
7.2.3 WuXi AppTec Biopharmaceutical CDMO Product and Services
7.2.4 WuXi AppTec Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 WuXi AppTec Recent Developments/Updates
7.2.6 WuXi AppTec Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Biopharmaceutical CDMO Product and Services
7.3.4 Catalent Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Thermo Fisher
7.4.1 Thermo Fisher Details
7.4.2 Thermo Fisher Major Business
7.4.3 Thermo Fisher Biopharmaceutical CDMO Product and Services
7.4.4 Thermo Fisher Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Recent Developments/Updates
7.4.6 Thermo Fisher Competitive Strengths & Weaknesses
7.5 Recipharm
7.5.1 Recipharm Details
7.5.2 Recipharm Major Business
7.5.3 Recipharm Biopharmaceutical CDMO Product and Services
7.5.4 Recipharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Recipharm Recent Developments/Updates
7.5.6 Recipharm Competitive Strengths & Weaknesses
7.6 Samsung Biologics
7.6.1 Samsung Biologics Details
7.6.2 Samsung Biologics Major Business
7.6.3 Samsung Biologics Biopharmaceutical CDMO Product and Services
7.6.4 Samsung Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Samsung Biologics Recent Developments/Updates
7.6.6 Samsung Biologics Competitive Strengths & Weaknesses
7.7 Siegfried
7.7.1 Siegfried Details
7.7.2 Siegfried Major Business
7.7.3 Siegfried Biopharmaceutical CDMO Product and Services
7.7.4 Siegfried Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Siegfried Recent Developments/Updates
7.7.6 Siegfried Competitive Strengths & Weaknesses
7.8 Delpharm
7.8.1 Delpharm Details
7.8.2 Delpharm Major Business
7.8.3 Delpharm Biopharmaceutical CDMO Product and Services
7.8.4 Delpharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Delpharm Recent Developments/Updates
7.8.6 Delpharm Competitive Strengths & Weaknesses
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Details
7.9.2 Boehringer Ingelheim Major Business
7.9.3 Boehringer Ingelheim Biopharmaceutical CDMO Product and Services
7.9.4 Boehringer Ingelheim Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Boehringer Ingelheim Recent Developments/Updates
7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.10 Aenova Group
7.10.1 Aenova Group Details
7.10.2 Aenova Group Major Business
7.10.3 Aenova Group Biopharmaceutical CDMO Product and Services
7.10.4 Aenova Group Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Aenova Group Recent Developments/Updates
7.10.6 Aenova Group Competitive Strengths & Weaknesses
7.11 AGC Parma Chemicals
7.11.1 AGC Parma Chemicals Details
7.11.2 AGC Parma Chemicals Major Business
7.11.3 AGC Parma Chemicals Biopharmaceutical CDMO Product and Services
7.11.4 AGC Parma Chemicals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AGC Parma Chemicals Recent Developments/Updates
7.11.6 AGC Parma Chemicals Competitive Strengths & Weaknesses
7.12 GenScript
7.12.1 GenScript Details
7.12.2 GenScript Major Business
7.12.3 GenScript Biopharmaceutical CDMO Product and Services
7.12.4 GenScript Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 GenScript Recent Developments/Updates
7.12.6 GenScript Competitive Strengths & Weaknesses
7.13 ProBioGen
7.13.1 ProBioGen Details
7.13.2 ProBioGen Major Business
7.13.3 ProBioGen Biopharmaceutical CDMO Product and Services
7.13.4 ProBioGen Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 ProBioGen Recent Developments/Updates
7.13.6 ProBioGen Competitive Strengths & Weaknesses
7.14 KBI Biopharma
7.14.1 KBI Biopharma Details
7.14.2 KBI Biopharma Major Business
7.14.3 KBI Biopharma Biopharmaceutical CDMO Product and Services
7.14.4 KBI Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 KBI Biopharma Recent Developments/Updates
7.14.6 KBI Biopharma Competitive Strengths & Weaknesses
7.15 3P Biopharmaceuticals
7.15.1 3P Biopharmaceuticals Details
7.15.2 3P Biopharmaceuticals Major Business
7.15.3 3P Biopharmaceuticals Biopharmaceutical CDMO Product and Services
7.15.4 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 3P Biopharmaceuticals Recent Developments/Updates
7.15.6 3P Biopharmaceuticals Competitive Strengths & Weaknesses
7.16 Rentschler Biopharma
7.16.1 Rentschler Biopharma Details
7.16.2 Rentschler Biopharma Major Business
7.16.3 Rentschler Biopharma Biopharmaceutical CDMO Product and Services
7.16.4 Rentschler Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Rentschler Biopharma Recent Developments/Updates
7.16.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.17 Northway Biotech
7.17.1 Northway Biotech Details
7.17.2 Northway Biotech Major Business
7.17.3 Northway Biotech Biopharmaceutical CDMO Product and Services
7.17.4 Northway Biotech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Northway Biotech Recent Developments/Updates
7.17.6 Northway Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biopharmaceutical CDMO Industry Chain
8.2 Biopharmaceutical CDMO Upstream Analysis
8.3 Biopharmaceutical CDMO Midstream Analysis
8.4 Biopharmaceutical CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biopharmaceutical CDMO Introduction
1.2 World Biopharmaceutical CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biopharmaceutical CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Biopharmaceutical CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biopharmaceutical CDMO Market Size (2018-2029)
1.3.3 China Biopharmaceutical CDMO Market Size (2018-2029)
1.3.4 Europe Biopharmaceutical CDMO Market Size (2018-2029)
1.3.5 Japan Biopharmaceutical CDMO Market Size (2018-2029)
1.3.6 South Korea Biopharmaceutical CDMO Market Size (2018-2029)
1.3.7 ASEAN Biopharmaceutical CDMO Market Size (2018-2029)
1.3.8 India Biopharmaceutical CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biopharmaceutical CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biopharmaceutical CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Biopharmaceutical CDMO Consumption Value (2018-2029)
2.2 World Biopharmaceutical CDMO Consumption Value by Region
2.2.1 World Biopharmaceutical CDMO Consumption Value by Region (2018-2023)
2.2.2 World Biopharmaceutical CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Biopharmaceutical CDMO Consumption Value (2018-2029)
2.4 China Biopharmaceutical CDMO Consumption Value (2018-2029)
2.5 Europe Biopharmaceutical CDMO Consumption Value (2018-2029)
2.6 Japan Biopharmaceutical CDMO Consumption Value (2018-2029)
2.7 South Korea Biopharmaceutical CDMO Consumption Value (2018-2029)
2.8 ASEAN Biopharmaceutical CDMO Consumption Value (2018-2029)
2.9 India Biopharmaceutical CDMO Consumption Value (2018-2029)
3 WORLD BIOPHARMACEUTICAL CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Biopharmaceutical CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biopharmaceutical CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biopharmaceutical CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Biopharmaceutical CDMO in 2022
3.3 Biopharmaceutical CDMO Company Evaluation Quadrant
3.4 Biopharmaceutical CDMO Market: Overall Company Footprint Analysis
3.4.1 Biopharmaceutical CDMO Market: Region Footprint
3.4.2 Biopharmaceutical CDMO Market: Company Product Type Footprint
3.4.3 Biopharmaceutical CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biopharmaceutical CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biopharmaceutical CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biopharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biopharmaceutical CDMO Consumption Value Comparison
4.2.1 United States VS China: Biopharmaceutical CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biopharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biopharmaceutical CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biopharmaceutical CDMO Revenue, (2018-2023)
4.4 China Based Companies Biopharmaceutical CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Biopharmaceutical CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biopharmaceutical CDMO Revenue, (2018-2023)
4.5 Rest of World Based Biopharmaceutical CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biopharmaceutical CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biopharmaceutical CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Development and Manufacturing CDMOs
5.2.2 Clinical Trial Material CDMOs
5.2.3 Fill-Finish CDMOs
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biopharmaceutical CDMO Market Size by Type (2018-2023)
5.3.2 World Biopharmaceutical CDMO Market Size by Type (2024-2029)
5.3.3 World Biopharmaceutical CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biopharmaceutical CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biopharmaceutical CDMO Market Size by Application (2018-2023)
6.3.2 World Biopharmaceutical CDMO Market Size by Application (2024-2029)
6.3.3 World Biopharmaceutical CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biopharmaceutical CDMO Product and Services
7.1.4 Lonza Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 WuXi AppTec
7.2.1 WuXi AppTec Details
7.2.2 WuXi AppTec Major Business
7.2.3 WuXi AppTec Biopharmaceutical CDMO Product and Services
7.2.4 WuXi AppTec Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 WuXi AppTec Recent Developments/Updates
7.2.6 WuXi AppTec Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Biopharmaceutical CDMO Product and Services
7.3.4 Catalent Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Thermo Fisher
7.4.1 Thermo Fisher Details
7.4.2 Thermo Fisher Major Business
7.4.3 Thermo Fisher Biopharmaceutical CDMO Product and Services
7.4.4 Thermo Fisher Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Recent Developments/Updates
7.4.6 Thermo Fisher Competitive Strengths & Weaknesses
7.5 Recipharm
7.5.1 Recipharm Details
7.5.2 Recipharm Major Business
7.5.3 Recipharm Biopharmaceutical CDMO Product and Services
7.5.4 Recipharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Recipharm Recent Developments/Updates
7.5.6 Recipharm Competitive Strengths & Weaknesses
7.6 Samsung Biologics
7.6.1 Samsung Biologics Details
7.6.2 Samsung Biologics Major Business
7.6.3 Samsung Biologics Biopharmaceutical CDMO Product and Services
7.6.4 Samsung Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Samsung Biologics Recent Developments/Updates
7.6.6 Samsung Biologics Competitive Strengths & Weaknesses
7.7 Siegfried
7.7.1 Siegfried Details
7.7.2 Siegfried Major Business
7.7.3 Siegfried Biopharmaceutical CDMO Product and Services
7.7.4 Siegfried Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Siegfried Recent Developments/Updates
7.7.6 Siegfried Competitive Strengths & Weaknesses
7.8 Delpharm
7.8.1 Delpharm Details
7.8.2 Delpharm Major Business
7.8.3 Delpharm Biopharmaceutical CDMO Product and Services
7.8.4 Delpharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Delpharm Recent Developments/Updates
7.8.6 Delpharm Competitive Strengths & Weaknesses
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Details
7.9.2 Boehringer Ingelheim Major Business
7.9.3 Boehringer Ingelheim Biopharmaceutical CDMO Product and Services
7.9.4 Boehringer Ingelheim Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Boehringer Ingelheim Recent Developments/Updates
7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.10 Aenova Group
7.10.1 Aenova Group Details
7.10.2 Aenova Group Major Business
7.10.3 Aenova Group Biopharmaceutical CDMO Product and Services
7.10.4 Aenova Group Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Aenova Group Recent Developments/Updates
7.10.6 Aenova Group Competitive Strengths & Weaknesses
7.11 AGC Parma Chemicals
7.11.1 AGC Parma Chemicals Details
7.11.2 AGC Parma Chemicals Major Business
7.11.3 AGC Parma Chemicals Biopharmaceutical CDMO Product and Services
7.11.4 AGC Parma Chemicals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AGC Parma Chemicals Recent Developments/Updates
7.11.6 AGC Parma Chemicals Competitive Strengths & Weaknesses
7.12 GenScript
7.12.1 GenScript Details
7.12.2 GenScript Major Business
7.12.3 GenScript Biopharmaceutical CDMO Product and Services
7.12.4 GenScript Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 GenScript Recent Developments/Updates
7.12.6 GenScript Competitive Strengths & Weaknesses
7.13 ProBioGen
7.13.1 ProBioGen Details
7.13.2 ProBioGen Major Business
7.13.3 ProBioGen Biopharmaceutical CDMO Product and Services
7.13.4 ProBioGen Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 ProBioGen Recent Developments/Updates
7.13.6 ProBioGen Competitive Strengths & Weaknesses
7.14 KBI Biopharma
7.14.1 KBI Biopharma Details
7.14.2 KBI Biopharma Major Business
7.14.3 KBI Biopharma Biopharmaceutical CDMO Product and Services
7.14.4 KBI Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 KBI Biopharma Recent Developments/Updates
7.14.6 KBI Biopharma Competitive Strengths & Weaknesses
7.15 3P Biopharmaceuticals
7.15.1 3P Biopharmaceuticals Details
7.15.2 3P Biopharmaceuticals Major Business
7.15.3 3P Biopharmaceuticals Biopharmaceutical CDMO Product and Services
7.15.4 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 3P Biopharmaceuticals Recent Developments/Updates
7.15.6 3P Biopharmaceuticals Competitive Strengths & Weaknesses
7.16 Rentschler Biopharma
7.16.1 Rentschler Biopharma Details
7.16.2 Rentschler Biopharma Major Business
7.16.3 Rentschler Biopharma Biopharmaceutical CDMO Product and Services
7.16.4 Rentschler Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Rentschler Biopharma Recent Developments/Updates
7.16.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.17 Northway Biotech
7.17.1 Northway Biotech Details
7.17.2 Northway Biotech Major Business
7.17.3 Northway Biotech Biopharmaceutical CDMO Product and Services
7.17.4 Northway Biotech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Northway Biotech Recent Developments/Updates
7.17.6 Northway Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biopharmaceutical CDMO Industry Chain
8.2 Biopharmaceutical CDMO Upstream Analysis
8.3 Biopharmaceutical CDMO Midstream Analysis
8.4 Biopharmaceutical CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biopharmaceutical CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biopharmaceutical CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biopharmaceutical CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biopharmaceutical CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biopharmaceutical CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biopharmaceutical CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biopharmaceutical CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biopharmaceutical CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biopharmaceutical CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biopharmaceutical CDMO Players in 2022
Table 12. World Biopharmaceutical CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biopharmaceutical CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Biopharmaceutical CDMO Player
Table 15. Biopharmaceutical CDMO Market: Company Product Type Footprint
Table 16. Biopharmaceutical CDMO Market: Company Product Application Footprint
Table 17. Biopharmaceutical CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Biopharmaceutical CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biopharmaceutical CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biopharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biopharmaceutical CDMO Revenue Market Share (2018-2023)
Table 23. China Based Biopharmaceutical CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biopharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biopharmaceutical CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biopharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biopharmaceutical CDMO Revenue Market Share (2018-2023)
Table 29. World Biopharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biopharmaceutical CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biopharmaceutical CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biopharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biopharmaceutical CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biopharmaceutical CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biopharmaceutical CDMO Product and Services
Table 38. Lonza Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. WuXi AppTec Basic Information, Area Served and Competitors
Table 42. WuXi AppTec Major Business
Table 43. WuXi AppTec Biopharmaceutical CDMO Product and Services
Table 44. WuXi AppTec Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. WuXi AppTec Recent Developments/Updates
Table 46. WuXi AppTec Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Biopharmaceutical CDMO Product and Services
Table 50. Catalent Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Major Business
Table 55. Thermo Fisher Biopharmaceutical CDMO Product and Services
Table 56. Thermo Fisher Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Recent Developments/Updates
Table 58. Thermo Fisher Competitive Strengths & Weaknesses
Table 59. Recipharm Basic Information, Area Served and Competitors
Table 60. Recipharm Major Business
Table 61. Recipharm Biopharmaceutical CDMO Product and Services
Table 62. Recipharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Recipharm Recent Developments/Updates
Table 64. Recipharm Competitive Strengths & Weaknesses
Table 65. Samsung Biologics Basic Information, Area Served and Competitors
Table 66. Samsung Biologics Major Business
Table 67. Samsung Biologics Biopharmaceutical CDMO Product and Services
Table 68. Samsung Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Samsung Biologics Recent Developments/Updates
Table 70. Samsung Biologics Competitive Strengths & Weaknesses
Table 71. Siegfried Basic Information, Area Served and Competitors
Table 72. Siegfried Major Business
Table 73. Siegfried Biopharmaceutical CDMO Product and Services
Table 74. Siegfried Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Siegfried Recent Developments/Updates
Table 76. Siegfried Competitive Strengths & Weaknesses
Table 77. Delpharm Basic Information, Area Served and Competitors
Table 78. Delpharm Major Business
Table 79. Delpharm Biopharmaceutical CDMO Product and Services
Table 80. Delpharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Delpharm Recent Developments/Updates
Table 82. Delpharm Competitive Strengths & Weaknesses
Table 83. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 84. Boehringer Ingelheim Major Business
Table 85. Boehringer Ingelheim Biopharmaceutical CDMO Product and Services
Table 86. Boehringer Ingelheim Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Boehringer Ingelheim Recent Developments/Updates
Table 88. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 89. Aenova Group Basic Information, Area Served and Competitors
Table 90. Aenova Group Major Business
Table 91. Aenova Group Biopharmaceutical CDMO Product and Services
Table 92. Aenova Group Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Aenova Group Recent Developments/Updates
Table 94. Aenova Group Competitive Strengths & Weaknesses
Table 95. AGC Parma Chemicals Basic Information, Area Served and Competitors
Table 96. AGC Parma Chemicals Major Business
Table 97. AGC Parma Chemicals Biopharmaceutical CDMO Product and Services
Table 98. AGC Parma Chemicals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AGC Parma Chemicals Recent Developments/Updates
Table 100. AGC Parma Chemicals Competitive Strengths & Weaknesses
Table 101. GenScript Basic Information, Area Served and Competitors
Table 102. GenScript Major Business
Table 103. GenScript Biopharmaceutical CDMO Product and Services
Table 104. GenScript Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. GenScript Recent Developments/Updates
Table 106. GenScript Competitive Strengths & Weaknesses
Table 107. ProBioGen Basic Information, Area Served and Competitors
Table 108. ProBioGen Major Business
Table 109. ProBioGen Biopharmaceutical CDMO Product and Services
Table 110. ProBioGen Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. ProBioGen Recent Developments/Updates
Table 112. ProBioGen Competitive Strengths & Weaknesses
Table 113. KBI Biopharma Basic Information, Area Served and Competitors
Table 114. KBI Biopharma Major Business
Table 115. KBI Biopharma Biopharmaceutical CDMO Product and Services
Table 116. KBI Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. KBI Biopharma Recent Developments/Updates
Table 118. KBI Biopharma Competitive Strengths & Weaknesses
Table 119. 3P Biopharmaceuticals Basic Information, Area Served and Competitors
Table 120. 3P Biopharmaceuticals Major Business
Table 121. 3P Biopharmaceuticals Biopharmaceutical CDMO Product and Services
Table 122. 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. 3P Biopharmaceuticals Recent Developments/Updates
Table 124. 3P Biopharmaceuticals Competitive Strengths & Weaknesses
Table 125. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 126. Rentschler Biopharma Major Business
Table 127. Rentschler Biopharma Biopharmaceutical CDMO Product and Services
Table 128. Rentschler Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Rentschler Biopharma Recent Developments/Updates
Table 130. Northway Biotech Basic Information, Area Served and Competitors
Table 131. Northway Biotech Major Business
Table 132. Northway Biotech Biopharmaceutical CDMO Product and Services
Table 133. Northway Biotech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Biopharmaceutical CDMO Upstream (Raw Materials)
Table 135. Biopharmaceutical CDMO Typical Customers
List of Figure
Figure 1. Biopharmaceutical CDMO Picture
Figure 2. World Biopharmaceutical CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biopharmaceutical CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biopharmaceutical CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biopharmaceutical CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Biopharmaceutical CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biopharmaceutical CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biopharmaceutical CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biopharmaceutical CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biopharmaceutical CDMO Markets in 2022
Figure 27. United States VS China: Biopharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biopharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biopharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biopharmaceutical CDMO Market Size Market Share by Type in 2022
Figure 31. Development and Manufacturing CDMOs
Figure 32. Clinical Trial Material CDMOs
Figure 33. Fill-Finish CDMOs
Figure 34. Other
Figure 35. World Biopharmaceutical CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Biopharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Biopharmaceutical CDMO Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Other
Figure 41. Biopharmaceutical CDMO Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Biopharmaceutical CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biopharmaceutical CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biopharmaceutical CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biopharmaceutical CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biopharmaceutical CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biopharmaceutical CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biopharmaceutical CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biopharmaceutical CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biopharmaceutical CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biopharmaceutical CDMO Players in 2022
Table 12. World Biopharmaceutical CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biopharmaceutical CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Biopharmaceutical CDMO Player
Table 15. Biopharmaceutical CDMO Market: Company Product Type Footprint
Table 16. Biopharmaceutical CDMO Market: Company Product Application Footprint
Table 17. Biopharmaceutical CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Biopharmaceutical CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biopharmaceutical CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biopharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biopharmaceutical CDMO Revenue Market Share (2018-2023)
Table 23. China Based Biopharmaceutical CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biopharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biopharmaceutical CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biopharmaceutical CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biopharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biopharmaceutical CDMO Revenue Market Share (2018-2023)
Table 29. World Biopharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biopharmaceutical CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biopharmaceutical CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biopharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biopharmaceutical CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biopharmaceutical CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biopharmaceutical CDMO Product and Services
Table 38. Lonza Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. WuXi AppTec Basic Information, Area Served and Competitors
Table 42. WuXi AppTec Major Business
Table 43. WuXi AppTec Biopharmaceutical CDMO Product and Services
Table 44. WuXi AppTec Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. WuXi AppTec Recent Developments/Updates
Table 46. WuXi AppTec Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Biopharmaceutical CDMO Product and Services
Table 50. Catalent Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Major Business
Table 55. Thermo Fisher Biopharmaceutical CDMO Product and Services
Table 56. Thermo Fisher Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Recent Developments/Updates
Table 58. Thermo Fisher Competitive Strengths & Weaknesses
Table 59. Recipharm Basic Information, Area Served and Competitors
Table 60. Recipharm Major Business
Table 61. Recipharm Biopharmaceutical CDMO Product and Services
Table 62. Recipharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Recipharm Recent Developments/Updates
Table 64. Recipharm Competitive Strengths & Weaknesses
Table 65. Samsung Biologics Basic Information, Area Served and Competitors
Table 66. Samsung Biologics Major Business
Table 67. Samsung Biologics Biopharmaceutical CDMO Product and Services
Table 68. Samsung Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Samsung Biologics Recent Developments/Updates
Table 70. Samsung Biologics Competitive Strengths & Weaknesses
Table 71. Siegfried Basic Information, Area Served and Competitors
Table 72. Siegfried Major Business
Table 73. Siegfried Biopharmaceutical CDMO Product and Services
Table 74. Siegfried Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Siegfried Recent Developments/Updates
Table 76. Siegfried Competitive Strengths & Weaknesses
Table 77. Delpharm Basic Information, Area Served and Competitors
Table 78. Delpharm Major Business
Table 79. Delpharm Biopharmaceutical CDMO Product and Services
Table 80. Delpharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Delpharm Recent Developments/Updates
Table 82. Delpharm Competitive Strengths & Weaknesses
Table 83. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 84. Boehringer Ingelheim Major Business
Table 85. Boehringer Ingelheim Biopharmaceutical CDMO Product and Services
Table 86. Boehringer Ingelheim Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Boehringer Ingelheim Recent Developments/Updates
Table 88. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 89. Aenova Group Basic Information, Area Served and Competitors
Table 90. Aenova Group Major Business
Table 91. Aenova Group Biopharmaceutical CDMO Product and Services
Table 92. Aenova Group Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Aenova Group Recent Developments/Updates
Table 94. Aenova Group Competitive Strengths & Weaknesses
Table 95. AGC Parma Chemicals Basic Information, Area Served and Competitors
Table 96. AGC Parma Chemicals Major Business
Table 97. AGC Parma Chemicals Biopharmaceutical CDMO Product and Services
Table 98. AGC Parma Chemicals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AGC Parma Chemicals Recent Developments/Updates
Table 100. AGC Parma Chemicals Competitive Strengths & Weaknesses
Table 101. GenScript Basic Information, Area Served and Competitors
Table 102. GenScript Major Business
Table 103. GenScript Biopharmaceutical CDMO Product and Services
Table 104. GenScript Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. GenScript Recent Developments/Updates
Table 106. GenScript Competitive Strengths & Weaknesses
Table 107. ProBioGen Basic Information, Area Served and Competitors
Table 108. ProBioGen Major Business
Table 109. ProBioGen Biopharmaceutical CDMO Product and Services
Table 110. ProBioGen Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. ProBioGen Recent Developments/Updates
Table 112. ProBioGen Competitive Strengths & Weaknesses
Table 113. KBI Biopharma Basic Information, Area Served and Competitors
Table 114. KBI Biopharma Major Business
Table 115. KBI Biopharma Biopharmaceutical CDMO Product and Services
Table 116. KBI Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. KBI Biopharma Recent Developments/Updates
Table 118. KBI Biopharma Competitive Strengths & Weaknesses
Table 119. 3P Biopharmaceuticals Basic Information, Area Served and Competitors
Table 120. 3P Biopharmaceuticals Major Business
Table 121. 3P Biopharmaceuticals Biopharmaceutical CDMO Product and Services
Table 122. 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. 3P Biopharmaceuticals Recent Developments/Updates
Table 124. 3P Biopharmaceuticals Competitive Strengths & Weaknesses
Table 125. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 126. Rentschler Biopharma Major Business
Table 127. Rentschler Biopharma Biopharmaceutical CDMO Product and Services
Table 128. Rentschler Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Rentschler Biopharma Recent Developments/Updates
Table 130. Northway Biotech Basic Information, Area Served and Competitors
Table 131. Northway Biotech Major Business
Table 132. Northway Biotech Biopharmaceutical CDMO Product and Services
Table 133. Northway Biotech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Biopharmaceutical CDMO Upstream (Raw Materials)
Table 135. Biopharmaceutical CDMO Typical Customers
List of Figure
Figure 1. Biopharmaceutical CDMO Picture
Figure 2. World Biopharmaceutical CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biopharmaceutical CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biopharmaceutical CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biopharmaceutical CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biopharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Biopharmaceutical CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biopharmaceutical CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biopharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biopharmaceutical CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biopharmaceutical CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biopharmaceutical CDMO Markets in 2022
Figure 27. United States VS China: Biopharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biopharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biopharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biopharmaceutical CDMO Market Size Market Share by Type in 2022
Figure 31. Development and Manufacturing CDMOs
Figure 32. Clinical Trial Material CDMOs
Figure 33. Fill-Finish CDMOs
Figure 34. Other
Figure 35. World Biopharmaceutical CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Biopharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Biopharmaceutical CDMO Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Other
Figure 41. Biopharmaceutical CDMO Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
